In addition, some molecular biological markers (such as epidermal growth factor receptor, thymidylate synthase, p21, and CEA) may also influence the response of colorectal carcinoma to chemoradiotherapy [28, 29]. The gene discussed is TYMS; the disease is colorectal carcinoma.